Upgrade to SI Premium - Free Trial

Waldencast agrees to sell Obagi Medical to Bridgepoint for up to $460 million

June 1, 2026 6:59 AM
Waldencast plc (NASDAQ: WALD) announced it entered into a definitive agreement to sell its Obagi Medical dermatological skincare business to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Mergers and Acquisitions